- Zilola oral formulation is an antihistamine. It works on the basis of levocetirizine dihydrochloride, which effectively relieves the symptoms of allergic (eg. Urticaria or hay fever).
1 tablet. powl. It contains 5 mg of levocetirizine dihydrochloride. Tablet core: microcrystalline cellulose, lactose monohydrate, colloidal anhydrous silica, magnesium stearate, tablet coating: Opadry 03B28796 White, 6cP containing hypromellose (E 464), titanium dioxide (E171), macrogol 400
Zilola is a drug that thanks to the content of levocetirizine dihydrochloride exhibits antihistamine. This contributes to significant relief of symptoms of allergic rhinitis (including persistent allergic rhinitis) and long-term hives of unknown origin (idopatycznej chronic urticaria). Including limits watery eyes, sneezing and runny nose, and itchy skin. Zilola is in the form of tablets intended for oral use.
- Hypersensitivity to the active components of the preparation
- severe renal impairment (severe renal failure with creatinine clearance below 10 ml / min)
- use in children under 2 years of age
It is recommended to use the product in adults and adolescents from 12 years of age in the case of allergic rhinitis and chronic urticaria idopatycznej.
For oral use. In adults and adolescents from 12 years of age it is recommended to use a dose of 1 tabl./24h.